26 unchanged sentences
The defendants filed a motion to dismiss the amended complaint on
−Removed: August 21, 2024, and denied on March 27, 2025, the court denied that motion.
+Added: August 21, 2024, and on March 27, 2025, the court denied that motion.
The parties are now engaged in fact discovery.
−Removed: Three shareholder derivative lawsuits piggy-backing on the Securities
−Removed: Class Action were filed in the United States District Court for the District of Nevada, allegedly on behalf of the Company, by three putative
−Removed: stockholders:
+Added: On February 13, 2026, Plaintiffs filed a motion for class certification and a motion for leave to file a second
+Added: amended complaint.
+Added: Defendants opposed the motion for leave to amend, and that motion is now fully briefed and pending before the court.
+Added: Defendants’ opposition to the motion for class certification is due June 15, 2026.
+Added: Three shareholder derivative lawsuits piggy-backing
+Added: on the Securities Class Action were filed in the United States District Court for the District of Nevada, allegedly on behalf of the Company,
+Added: by three putative stockholders:
Andrew Hulm on December 30, 2024;
−Removed: William Settel on April 28, 2025 and Cline Wilkerson on September 11, 2025, (collectively
−Removed: the “Related Derivative Lawsuits”).
−Removed: Each Related Derivative Lawsuit names the same current and former officers and directors
−Removed: as defendants and alleges essentially the same claims:
−Removed: that the defendants breached their fiduciary duties by causing or failing to prevent
−Removed: the securities violations alleged in the Securities Class Action, and related claims for unjust enrichment, waste of corporate assets,
−Removed: gross mismanagement, and abuse of control.
−Removed: On September 29, 2025, at the request of the parties, the court consolidated all three Related
−Removed: Derivative Lawsuits under the caption In re BioVie Inc .
+Added: William Settel on April 28, 2025 and Cline Wilkerson on September 11,
+Added: 2025, (collectively the “Related Derivative Lawsuits”).
+Added: Each Related Derivative Lawsuit names the same current and former
+Added: officers and directors as defendants and alleges essentially the same claims:
+Added: that the defendants breached their fiduciary duties by causing
+Added: or failing to prevent the securities violations alleged in the Securities Class Action, and related claims for unjust enrichment, waste
+Added: of corporate assets, gross mismanagement, and abuse of control.
+Added: On September 29, 2025, at the request of the parties, the court consolidated
+Added: all three Related Derivative Lawsuits under the caption In re BioVie Inc .
Derivative Litigation , Case No.
−Removed: 3:24-cv-0602-CSD (the “Consolidated
−Removed: Derivative Action”).
−Removed: On January 27, 2026, at the request of the parties, the court stayed the Consolidated Derivative Action pending
−Removed: resolution of a summary judgment motion by defendants in the Securities Class Action.
+Added: 3:24-cv-0602-CSD
+Added: (the “Consolidated Derivative Action”).
+Added: On January 27, 2026, at the request of the parties, the court stayed the Consolidated
+Added: Derivative Action pending resolution of a summary judgment motion by defendants in the Securities Class Action.
The Company believes that the claims are without
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.